Around the world there are 33.5 million patients suffering from atrial fibrillation (AF) with an
annual increase of 5 million cases. Most AF patients have an established form of an atrial …

Obesity is a worldwide health problem with epidemic proportions that has been associated
with atrial fibrillation (AF). Even though the underlying pathophysiological mechanisms have …

Context Observational studies have suggested associations between adipokines and
cardiovascular disease (CVD), but the roles of certain adipokines remain controversial, and …

Objective: To describe the relationship between circulating resistin levels and
cardiovascular diseases (CVD) and all-cause death in a multi-ethnic cohort. Methods and …

The obesity epidemic is swelling to epic proportions. Obese patients often suffer from a
combination of hypertension, dyslipidemia, and type 2 diabetes mellitus (T2DM), also known …

Introduction: Obesity, defined as a Body Mass Index (BMI) of≥ 30 kg/m2, is the most
common chronic metabolic disease worldwide and its prevalence has been strongly …

Purpose Atrial fibrillation (AF) has been associated with increased volumes of epicardial fat
and atrial adipocyte accumulation. Underlying mechanisms are not well understood. This …

Objectives Higher body mass index (BMI) is an important risk factor for atrial fibrillation (AF).
The adipokines leptin, adiponectin and resistin are correlates of BMI, but their association …

Obesity increases the risk of atrial fibrillation (AF), potentially through proteins secreted by
adipose tissue (AT) that affect atrial electrical and structural remodeling. We aim to give a …

Background Fibroblast growth factor 21 (FGF-21), a newly discovered adipokine, plays an
important role in glucose and lipid metabolism and is associated with the development of …